Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002099657 | SCV002323940 | likely benign | Hereditary spastic paraplegia 63; Pontocerebellar hypoplasia type 9 | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003408105 | SCV004124191 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | AMPD2: BP4, BP7 |
Breakthrough Genomics, |
RCV003408105 | SCV005259258 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003911171 | SCV004719232 | likely benign | AMPD2-related disorder | 2019-11-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |